The European pharmaceutical preparations labor costs per employee FTE in 2023 reveal significant disparities across countries. Iceland leads with the highest cost of 202.9 thousand euros, followed by Switzerland at 186.5, while Romania stands at the lowest with 20.1. Notably, Western European countries like Belgium and Germany show higher labor costs, indicating developed markets with substantial investments in pharmaceutical activities. In contrast, Eastern European countries like Romania, Poland, and Hungary maintain much lower labor costs, depicting growing yet cost-effective markets for pharmaceutical operations.
Looking ahead, anticipated trends include potential shifts due to economic fluctuations and policy changes in the European Union, labor cost adjustments influenced by technological advancements like automation, and varying strategies related to workforce restructuring and specialization to meet global pharmaceutical demands. Market players should monitor these trends to strategize effectively.
Top countries in Pharmaceutical Preparations Labour Cost Per Employee FTE by Country
| # | 10 Countries | Thousand Euros | Last Year | |
|---|---|---|---|---|
| 1 | 1 Iceland | 202.9 | 2023 | View data |
| 2 | 2 Switzerland | 186.5 | 2023 | View data |
| 3 | 3 Belgium | 147.9 | 2023 | View data |
| 4 | 4 Germany | 120.3 | 2023 | View data |
| 5 | 5 Italy | 94.5 | 2023 | View data |
| 6 | 6 Austria | 92.8 | 2023 | View data |
| 7 | 7 Netherlands | 89 | 2023 | View data |
| 8 | 8 Spain | 58 | 2023 | View data |
| 9 | 9 Greece | 35.9 | 2023 | View data |
| 10 | 10 Hungary | 32 | 2023 | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...